Zobrazeno 1 - 10
of 1 963
pro vyhledávání: '"Mezzanzanica D"'
Autor:
Capoluongo, E.D., Pellegrino, B., Arenare, L., Califano, D., Scambia, G., Beltrame, L., Serra, V., Scaglione, G.L., Spina, A., Cecere, S.C., De Cecio, R., Normanno, N., Colombo, N., Lorusso, D., Russo, D., Nardelli, C., D’Incalci, M., Llop-Guevara, A., Pisano, C., Baldassarre, G., Mezzanzanica, D., Artioli, G., Setaro, M., Tasca, G., Roma, C., Campanini, N., Cinieri, S., Sergi, A., Musolino, A., Perrone, F., Chiodini, P., Marchini, S., Pignata, S.
Publikováno v:
In ESMO Open October 2022 7(5)
Autor:
Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: c.l.creutzberg@lumc.nl., Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Eminowicz G; Department of Clinical Oncology, University College London Hospital, London, UK., Allanson E; Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, Perth, WA, Australia., Eberst L; Department of Medical Oncology, Institut de Cancérologie de Strasbourg, Strasbourg, France., Kim SI; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Nout RA; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, Netherlands., Park JY; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Lorusso D; Gynecologic Oncology Unit, Humanitas San Pio X, Milan, Italy; Humanitas University Rozzano, Milan, Italy., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, VIC, Australia., Ottevanger PB; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Brand A; Department of Gynaecological Oncology, Westmead Hospital and University of Sydney, Sydney, NSW, Australia., Mezzanzanica D; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Oza A; Division of Medical Oncology and Hematology, UHN - Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Pothuri B; Perlmutter Cancer Center, NYU Langone Health, New York, NJ, USA; Diversity and Health Equity for Clinical Trials, GOG-Foundation, Philadelphia, PA USA., Batley T; Ko Ngai Tūhoe te iwi, Kaitauwhiro Mātātahi Mokopuna Ora, Te Pūtahitanga o Te Waipounamu, Christchurch, New Zealand., Gordon C; Canadian Cancer Trials Group, London, ON, Canada., Mitra T; Kolkata Gynecological Oncology Trials and Translational Research Group (KolGOTrg), New Town, Kolkata, India., White H; Peaches Womb Cancer Trust, Manchester, UK; Cancer Research Advocates Forum, London, UK., Howitt B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Matias-Guiu X; Department of Pathology, Hospital U de Bellvitge, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital U Arnau de Vilanova, University of Lleida, Lleida, Spain., Ray-Coquard I; Centre Leon Berard and Université Claude Bernard, Lyon, France., Gaffney D; Huntsman Cancer Institute, Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA., Small W Jr; Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, IL, USA., Miller A; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Concin N; Department of Gynaecology and Gynaecological Oncology, Medical University of Vienna, Vienna, Austria; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria., Powell MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA., Stuart G; Department of Obstetrics and Gynecology, University of British Colombia, Vancouver, BC, Canada., Bookman MA; Kaiser Permanente Northern California, San Francisco, CA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. e420-e431.
Autor:
Capoluongo ED, B, Pellegrino, Arenare L, Califano D, Scambia G, L, Beltrame, V, Serra, Scaglione GL, Spina A, Cecere SC, De Cecio R, N, Normanno, N, Colombo, Lorusso D, Russo D, Nardelli C, M, D'Incalci, Llop-Guevara A, Pisano C, G, Baldassarre, Mezzanzanica D, Artioli G, Setaro M, Tasca G, C, Roma, Campanini N, Cinieri S, A, Sergi, Musolino A, Perrone F, Chiodini P, S, Marchini, Pignata S
Publikováno v:
Scientia
Molecular testing; Ovarian cancer Proves moleculars; Càncer d'ovaris Pruebas moleculares; Cáncer de ovarios Background The detection of homologous recombination deficiency (HRD) can identify patients who are more responsive to platinum and poly ADP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf39ab4ed238d4e922aed12d4c930dd
https://hdl.handle.net/11351/8362
https://hdl.handle.net/11351/8362
Autor:
Ricci A; Notified Body 0373 Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Dugo M; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Pisanu ME; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., De Cecco L; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Raspagliesi F; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy., Valeri B; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy., Veneroni S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Chirico M; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Palombelli G; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Daidone MG; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Podo F; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Canese R; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Mezzanzanica D; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Bagnoli M; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Iorio E; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Publikováno v:
Journal of proteome research [J Proteome Res] 2024 Jan 05; Vol. 23 (1), pp. 483-493. Date of Electronic Publication: 2023 Dec 18.
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
Autor:
Corno, C., D’Arcy, P., Bagnoli, M., Paolini, B., Costantino, M., Carenini, N., Corna, E., Alberti, P., Mezzanzanica, D., Colombo, D., Linder, S., Arrighetti, N., Perego, P.
Publikováno v:
Frontiers in cell and developmental biology. 10
The identification of therapeutic approaches to improve response to platinum-based therapies is an urgent need for ovarian carcinoma. Deubiquitinases are a large family of ubiquitin proteases implicated in a variety of cellular functions and may cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6b1859d9e035bd34c7047f0d54d5656
https://pubmed.ncbi.nlm.nih.gov/36578788
https://pubmed.ncbi.nlm.nih.gov/36578788
Autor:
Forlani L; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., De Cecco L; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Simeon V; Department of Mental Health and Public Medicine, Section of Statistics, Università Degli Studi Della Campania Luigi Vanvitelli, 80138, Naples, Italy., Paolini B; Department of Pathology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Bagnoli M; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Cecere SC; Urogynaecological Medical Oncology, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Spina A; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Citeroni E; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Bignotti E; Division of Obstetrics and Gynecology, ASST Spedali Civili Di Brescia, Brescia, Italy.; Angelo Nocivelli Institute of Molecular Medicine, ASST Spedali Civili of Brescia- University of Brescia, Brescia, Italy., Lorusso D; Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, and Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Arenare L; Clinical Trials Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Russo D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., De Angelis C; Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy., Ardighieri L; Department of Pathology, Azienda Socio Sanitaria Territoriale Spedali Civili Di Brescia, Brescia, Italy., Scognamiglio G; Pathology Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Del Sesto M; Pathology Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Tognon G; Division of Obstetrics and Gynecology, ASST Spedali Civili Di Brescia, Brescia, Italy., Califano D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Schettino C; Clinical Trials Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Chiodini P; Department of Mental Health and Public Medicine, Section of Statistics, Università Degli Studi Della Campania Luigi Vanvitelli, 80138, Naples, Italy., Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Mezzanzanica D; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. delia.mezzanzaniza@istitutotumori.mi.it., Pignata S; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, 80131, Naples, Italy., Tomassetti A; Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. antonella.tomassetti@istitutotumori.mi.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Apr 11; Vol. 42 (1), pp. 83. Date of Electronic Publication: 2023 Apr 11.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Canese R; NMR and MRI Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Palombelli G; NMR and MRI Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Chirico M; NMR and MRI Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Sestili P; Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Bagnoli M; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Canevari S; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mezzanzanica D; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Podo F; NMR and MRI Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Iorio E; NMR and MRI Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
Publikováno v:
NMR in biomedicine [NMR Biomed] 2019 Oct; Vol. 32 (10), pp. e4016. Date of Electronic Publication: 2018 Oct 30.
Autor:
Fabbi M; UO Bioterapie, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Costa D; UO Oncologia Molecolare e Angiogenesi, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Russo D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Arenare L; Clinical Trials Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Gaggero G; UO Anatomia Patologica Ospedaliera, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Signoriello S; Department of Mental Health and Public Medicine, Section of Statistics, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy., Scambia G; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, 00168 Rome, Italy., Pisano C; Urogynecological Medical Oncology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Colombo N; European Institute of Oncology IRCCS, University of Milan-Bicocca, 20126 Milan, Italy., Losito NS; Pathology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Filaci G; UO Bioterapie, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.; Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy., Spina A; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Califano D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Scognamiglio G; Pathology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Gadducci A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, 56127 Pisa, Italy., Mezzanzanica D; Molecular Therapies Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Bagnoli M; Molecular Therapies Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Ferrini S; UO Bioterapie, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Canzonieri V; Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy., Chiodini P; Department of Mental Health and Public Medicine, Section of Statistics, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy., Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy., Pignata S; Urogynecological Medical Oncology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Aug 31; Vol. 12 (9). Date of Electronic Publication: 2022 Aug 31.
Autor:
Bagnoli M; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Nicoletti R; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Valitutti M; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rizzo A; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Napoli A; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Montalvão De Azevedo R; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tomassetti A; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mezzanzanica D; Department of Research, Unit of Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jul 18; Vol. 12, pp. 923508. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).